These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2339350)

  • 1. Premature arterial disease associated with familial antithrombin III deficiency.
    Johnson EJ; Prentice CR; Parapia LA
    Thromb Haemost; 1990 Feb; 63(1):13-5. PubMed ID: 2339350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral thromboembolism due to antithrombin III deficiency in two children.
    Vomberg PP; Breederveld C; Fleury P; Arts WF
    Neuropediatrics; 1987 Feb; 18(1):42-4. PubMed ID: 3561706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III deficiency appearing as mesenteric vein thrombosis.
    Pokorney BH; Eyster ME; Jeffries GH
    Am J Gastroenterol; 1981 Dec; 76(6):534-7. PubMed ID: 7331986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary protein S deficiency in young adults with arterial occlusive disease.
    Allaart CF; Aronson DC; Ruys T; Rosendaal FR; van Bockel JH; Bertina RM; Briët E
    Thromb Haemost; 1990 Oct; 64(2):206-10. PubMed ID: 2148653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial deficiency of antithrombin III].
    Coget JM; Dendien-Bernard S; Dupuis-Cuny C
    Phlebologie; 1987; 40(2):381-91. PubMed ID: 3615614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
    Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
    Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
    Eid SS
    Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical implications of antithrombin III deficiency.
    Karl R; Garlick I; Zarins C; Cheng E; Chediak J
    Surgery; 1981 Apr; 89(4):429-33. PubMed ID: 7209791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxymetholone therapy in patients with familial antithrombin III deficiency.
    Shibuya A; Ninomiya H; Nakazawa M; Nagasawa T; Yoda Y; Abe T
    Thromb Haemost; 1988 Dec; 60(3):495-7. PubMed ID: 3238652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.
    Vikydal R; Korninger C; Kyrle PA; Niessner H; Pabinger I; Thaler E; Lechner K
    Thromb Haemost; 1985 Dec; 54(4):744-5. PubMed ID: 4089808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma antithrombin III deficiency in ischaemic stroke in the young.
    Nagaraja D; Christopher R; Tripathi M
    Neurol India; 1999 Jun; 47(2):155-6. PubMed ID: 10402346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombin III deficiency as a risk factor in postoperative thrombosis].
    Van Betsbrugge M
    Acta Chir Belg; 1985; 85(5):299-302. PubMed ID: 4082851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.